Great Debates in GI Malignancies

Last Modified: October 12, 2007

Share article

Conference Dates: November 16-17, 2007
Conference Location: Santa Monica, California, USA

Sponsoring Group: Imedex

Conference Web Page URL:

Who Should Attend: Oncologists, other physicians, physicians-in-training, and healthcare professionals (nurses and pharmacists)

Registration Information: Please register at or call +1(678)242-0906

Continuing Education: Yes

Regorafenib Efficacious in GI Malignant Disease

Nov 26, 2012 - For patients with metastatic colorectal cancer or gastrointestinal stromal tumors who have progressed in spite of treatment, the multikinase inhibitor regorafenib may improve survival, according to the results of two phase 3 studies published online Nov. 22 in The Lancet.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More